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Abstract
Background: Emergence and global dissemination of multiresistant strains of enteric pathogens is a very concerning
problem from both epidemiological and Public Health points of view. Shigella sonnei is the serogroup of Shigella most
frequently responsible for sporadic and epidemic enteritis in developed countries. The dissemination is associated most
often to human to human transmission, but foodborne episodes have also been described. In recent years the circulation
of multiresistant strains of S. sonnei biotype g carrying a class 2 integron has been reported in many countries worldwide.
In southern Italy a strain with similar properties has been responsible for a large community outbreak occurred in 2003
in Palermo, Sicily.
The objective of this study was to date the emergence of the biotype g strain carrying the class 2 integron in southern
Italy and to evaluate the genetic heterogeneity of biotype g S. sonnei isolated throughout an extended interval of time.
Methods: A total of 31 clinical isolates of S. sonnei biotype g identified in southern Italy during the years 1971–2000 were
studied. The strains were identified at the serogroup level, characterized by biochemical tests and submitted to
antimicrobial susceptibility testing. Molecular typing was performed by pulsed field gel electrophoresis (PFGE) after
digestion of DNA by XbaI. Carriage of class 2 integrons was investigated by polymerase chain reaction (PCR) with specific
primers and confirmed by restriction endonuclease analysis of amplicons.
Results: The 15 isolates of S. sonnei biotype g identified in the decade 1971–1980 showed highly heterogeneous drug
resistance profiles and pulsotypes. None of the isolates was simultaneous resistant to streptomycin and trimethoprim
and none was class 2 integron positive. On the contrary, this resistance phenotype and class 2 integron carriage were
very common among the 16 strains of biotype g identified in the following two decades. Moreover, all the more recent
isolates, but one, showed closely related pulsotypes.
Conclusion: Although our findings refer to a limited geographic area, they provide a snapshot of integron acquisition
by an enteric pathogen responsible for several outbreaks in the years 2001–2003 in Italy. Molecular typing, indeed,
suggests that the emergence of biotype g class 2 integron carrying S. sonnei in southern Italy should be backdated to at
least the late 1980s. In the following decades, the circulation of biotype g appears to be sustained by multiresistant highly
related strains. Similar trend are described in several countries, but the questions about mechanism of emergence and
worldwide spread of this pathogen remain open.
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Background
The issue of emergence and global dissemination of mul-
tiresistant strains of enteric pathogens is of greatest inter-
est from both epidemiological and prevention/control
points of view. Whereas emergence is unavoidable, the
successful and persistent dissemination through widest
geographic areas of a resistant strain needs to be sup-
ported by the selective pressure due to the large use of
antibiotics [1].
Shigella sonnei is the major agent of shigellosis in devel-
oped countries, where sanitation and environmental
hygiene have largely interrupted the preferential transmis-
sion routes of other serogroups of Shigella, like dysenteriae,
boydii and flexneri [2]. In recent years, several reports on S.
sonnei epidemiology from different countries have associ-
ated the epidemic circulation of this organism to a well
defined strain, characterized by some properties: lack of
rhamnose fermentation (biotype g), a resistant phenotype
streptomycin-sulfonamide-trimethoprim and, less con-
sistently, tetracycline, a distinct XbaI pulsotype and the
presence of a 2.2 Kbp class 2 integron [3-9]. Although a
direct comparison between strains from different coun-
tries has not been reported until now, the findings by var-
ious authors seem to be suggestive of a worldwide
occurrence of cases due to a pandemic strain of S. sonnei
[7].
In southern Italy, during the period May-December 2003
a large community outbreak of shigellosis involved chil-
dren and young adults in Palermo, Sicily. Phenotypic and
genetic characterization of the isolates identified at the
Centre for Enteric Pathogens of southern Italy (CEPIM)
showed that S. sonnei biotype g carrying class 2 integrons
and showing a peculiar pulsotype was responsible for this
event [7].
During the previous decades, isolation of S. sonnei biotype
g in southern Italy had a very irregular trend: in the decade
1971–'80 it accounted for 17.5% (72 of 412) of the iso-
lates of S. sonnei, whereas in the next decade 1981–'90 for
3.5% (26 of 779) and in the years 1991–2000 for 71.4%
(40 of 56) [10]. This last period was characterized by a
striking decline in cases of S. sonnei infection, most fre-
quently occurring within patent epidemic events: indeed,
28 of the 40 biotype g isolates were from a community
outbreak occurring in 1991 in Palermo, Sicily.
The objective of this study was to date the emergence of
the biotype g strain carrying the class 2 integron in south-
ern Italy and to evaluate by pulsed field gel electrophore-
sis (PFGE) the genetic heterogeneity of biotype g S. sonnei
isolated throughout an extended interval of time.
Methods
Bacterial strains
A total of 31 clinical isolates of S. sonnei biotype g identi-
fied in southern Italy during the years 1971–2000 were
studied. The sample was chosen on the basis of available
epidemiological information, that suggested that a high
proportion of the isolates in the period 1981–2000 clus-
tered in three groups: indeed, 12 isolates were identified
in Brindisi, Apulia, in October 1989, 12 in Brindisi also,
but in January 1990, and 28 in Palermo, Sicily, in Octo-
ber-November 1991. However, except for the isolates
from Palermo, the temporal clusters had not been for-
mally recognized as epidemic events by the Public Health
services. The 31 strains, then, included: 15 randomly cho-
sen isolates out of 72 identified in the years 1971–1980;
eight of 26 isolates identified in the years 1981–1990, all
belonging to the two clusters of cases of Brindisi in 1989
and 1990; eight of 40, seven of which apparently sporadic,
identified in the years 1991–2000.
The strains had been identified at the serogroup level. and
characterized by biochemical tests at the CEPIM by previ-
ously described methods [10]. Antimicrobial susceptibil-
ity testing was performed by the disk diffusion method as
recommended by the National Committee of Clinical
Laboratory Standards [11]. The following antimicrobial
agents were tested (the disk content is indicated in paren-
theses): ampicillin, Ap (10 μg), chloramphenicol, Cm (30
μg), streptomycin, Sm (10 μg), sulfonamides, Su (300
μg), tetracycline, Tc (30 μg) trimethoprim, Tp (5 μg), cip-
rofloxacin, Cp (5 μg), kanamycin, Km (30 μg) and nalid-
ixic acid, Na (30 μg). Escherichia coli ATCC 25922 was
used as a control. The disks were obtained from Oxoid
(Basingstoke, United Kingdom).
Pulsed Field Gel Electrophoresis (PFGE)
S. sonnei isolates were grown in 3 ml Brain Hearth Infu-
sion (BHI) broth at 37°C overnight. The cells were pel-
leted, washed and resuspended in 1 ml of 75 mM NaCl,
25 mM EDTA. Then they were mixed with the same vol-
ume of 1.2% agarose gel (pulsed-field grade; Bio-Rad,
Hercules, CA, USA) and poured into the slots of a plastic
mould (CHEF DRII; Bio-Rad). The agarose plugs obtained
were transferred into the lysis buffer (50 mM Tris-HCl, pH
7.2, 50 mM EDTA, 1.0% N-laurylsarcosine and 0.1 mg/ml
proteinase K) and cells were lysed for 16–20 h at 55°C.
Then, the agarose plugs were washed five times for 30 min
with washing buffer (10 mM Tris-HCl, pH 8.0, 1 mM
EDTA) with gently shaking and stored in the same buffer
at 4°C.
A 1-mm slice of each agarose plug was equilibrated in 100
μl restriction buffer for 30 min and digested at 37°C for
18 h with 50 units XbaI (Promega, Madison, WI, USA).
After digestion, genomic DNA was separated in 1% agar-BMC Infectious Diseases 2006, 6:117 http://www.biomedcentral.com/1471-2334/6/117
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ose gel with a contour-clamped homogeneous electric
field apparatus (CHEF-DRIII, Bio-Rad Laboratories). The
conditions for electrophoresis were 6 V/cm for 21 h with
the pulse time increasing from 5 to 40 s. The strain of Sal-
monella serotype Braenderup H9812 restricted with XbaI
was used as molecular weight standard. Strain H9812 was
kindly provided by the National Reference Centre for
Enteric Pathogens at Istituto Superiore di Sanità, Rome,
Italy. PFGE patterns were initially visually assessed and
interpreted by using the criteria established by Tenover et
al. [12]. Computer-assisted analysis of the PFGE banding
patterns was performed with the Diversity Database soft-
ware (Bio-Rad Laboratories).
Integron analysis
To detect the class 2 integrons polymerase chain reaction
(PCR) was performed with the specific primer pair hep74
(5'-CGGGATCCCGG AGGCATGCACGATTTGTA-3') and
hep51 (5'-ATGCCATCGCAAGTACGAG-3'). Primer
hep74 binds to attI2, and hep51 binds to orfX, situated at
the right end of the cassette region within transposon Tn7
[13]. Tn7-containing strain Escherichia coli K-12 J62
(ColE1::Tn7) was used as positive control strain [6,7]. To
each reaction mixture was added 100 ng of template DNA,
1.5 mM MgCl2, each deoxynucleoside triphosphate at a
concentration of 200 μM, 5 μl of 10× PCR buffer (50 mM
Tris-HCl [pH 8.0], 100 mM NaCl, 0.1 mM EDTA, 1 mM
dithiothreitol, 50% glycerol, 1% Triton X-100), 25 pmol
of each primer, and 2.5 U of Taq  DNA polymerase
(Promega) in a final reaction volume of 50 μl. Amplifica-
tion was performed by using the following temperature
profile: pre-denaturation at 94°C for 10 min, followed by
35 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for
5 min, with a final extension step at 72°C for 5 min. The
amplified DNA products were analyzed by conventional
1% agarose gel electrophoresis in 1× TBE buffer and
stained with ethidium bromide. The similarity among the
2.2-kb amplicons of the E. coli reference strain and S. son-
nei isolates was investigated by restriction analysis with
the endonucleases AvaI, HincII and HinfI [7].
Results
S. sonnei isolates identified in the period 1971–1980
Six different susceptibility patterns were identified, with
five isolates being susceptible to the tested panel of anti-
bacterial drugs. None of the isolates was simultaneous
resistant to streptomycin and trimethoprim. PCR for class
2 integrons tested negative for all isolates (Table 1). Fif-
teen different unrelated or poorly related pulsotypes were
identified: except for two virtually identical profiles (Fig.
1, lanes 2 and 15), only one pair of isolates, indeed,
showed less than seven different bands (Fig. 1, lanes 3 and
5), whereas all the remaining were heterogeneous (Fig. 1).
S. sonnei isolates identified in the period 1981–1990
The eight strains exhibited two different resistance pat-
terns, differing only by susceptibility to ampicillin. A
SmSuTpTc pattern was identified in seven strains (Table
1). A class 2 integron was present in all isolates, that
shared also the same pulsotype (Fig. 2). The sequence
similarity of the 2.2-kb amplicons obtained from S. sonnei
isolates and the Tn7 containing reference strain of E. coli
was confirmed by identity of AvaI, HincII and HinfI restric-
tion patterns.
S. sonnei isolates identified in the period 1991–2000
Two different susceptibility patterns, differing by suscepti-
bility to tetracycline, were identified within these eight
strains. All strains, but one identified in Palermo, Sicily,
during 1995, were positive for class 2 integrons (Table 1).
Restriction endonuclease analysis confirmed the similar-
ity of the amplicons obtained from these further isolates
and the reference strain. All strains, but one (Fig. 2, lane
8) identified from an apparently sporadic case occurred in
1991 in Reggio Calabria, Calabria, exhibited closely
related pulsotypes (Fig. 2).
A phenotypic and genetic comparison between the iso-
lates identified in the period 1981–2000 and the outbreak
strain of Palermo, 2003, showed a close relationship:
indeed, 11 of 16 strains had identical susceptibility pat-
terns and a class 2 integron and showed highly related
PFGE patterns (Fig. 2).
Discussion
Shifting of serogroups of Shigella from flexneri to sonnei
and the steady progression from high endemicity to low
endemicity and, eventually, an epidemiological mix of
sporadic cases and infrequent outbreaks parallel the evo-
lution from developing to developed countries [2]. In our
geographic area, this trend has been observed in the last
decades in association with an additional epidemiological
aspect: the endemic phase appeared to be associated with
biotype a, whereas the more recent epidemic clusters to
biotype g [7,10]. Other European countries have noticed
a similar behaviour of Shigella and in many other regions
worldwide biotype g or rhamnose negative strains could
be included among the emergent organisms [4].
Our findings show that strains of S. sonnei biotype g circu-
lating in southern Italy in the first decade under study
were heterogeneous by PFGE and drug resistance pattern
and class 2 integron free. Within isolates of the following
decades, two features turned to be a consistent and dis-
tinctive genetic marker: carriage of integrons and a sub-
stantial homogeneity of PFGE profiles. A subsequent step
may be recognized in the outbreak phase, when closely
related, class 2 integron-carrying strains of biotype g have
been identified as the etiologic agent of a communitywideBMC Infectious Diseases 2006, 6:117 http://www.biomedcentral.com/1471-2334/6/117
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epidemic event occurring in 2003 in Palermo, Sicily [7].
Lombardy also, a region of Northern Italy, experienced in
2001 three classic outbreaks in two daycare centres and a
small community, that were attributed to a highly related
strain of S. sonnei biotype g [7].
Simultaneous emergence in widespread different areas of
infectious agents having humans as principal reservoir is
more difficult to justify than that of zoonotic organisms,
especially those preferentially transmitted through the
food chain. However, several foodborne outbreaks caused
by S. sonnei and prominently vehicled by fresh produce
have been reported worldwide [14-16]. Moreover, S. son-
nei has been proved to be able to survive in food also in
apparently hostile ecological conditions [17]
The question whether spread in many countries of S. son-
nei biotype g could be associated to a common food vehi-
cle or the emergence from an endemic pool of bacterial
strains and subsequent dissemination of more biologi-
cally fit organisms cannot be readily answered. A great
contribute can be provided by collaborative molecular
epidemiological studies adopting standardized method-
Table 1: Characteristics of the isolates included in the study
Years Number of isolates Susceptibility pattern Class 2 integron
1971–1980 5 Susceptible Negative
4S m S u T c"
3S m S u"
1 SmSuCmTc "
1S m S u C m"
1S u"
1981–1990 7 SmSuTcTp Positive
1 ApSmSuTcTp Positive
1991–2000 5 SmSuTcTp Positive
1 SmSuTcTp Negative
2 SmSuTp Positive
Ap = ampicillin; Cm = cloramphenicol; Sm = streptomycin; Su = sulfonamides; Tc = tetracycline; Tp = trimethoprim
PFGE profiles of the Shigella sonnei biotype g isolates, 1981– 2000 Figure 2
PFGE profiles of the Shigella sonnei biotype g isolates, 
1981–2000. Lanes: 1, Salmonella Braenderup H9812 (molec-
ular weight standard); 2–12, S. sonnei biotype g isolates: 2, 
epidemic strain, Palermo, Italy, 2003; 3, Brindisi, Apulia, 1989; 
4, Brindisi 1990; 5, Palermo 1991; 6, Palermo 1994; 7, Pal-
ermo 1995; 8, Reggio Calabria, Calabria, 1991; 9, Palermo 
1994; 10; Palermo 1995; 11, Messina, Sicilia, 1993; Palermo 
1996.
1      2      3      4       5      6       7       8       9 10     11     12 Kbp
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398.4
336.5     
310.1
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33.3
PFGE profiles of the Shigella sonnei biotype g isolates, 1971– 1980 Figure 1
PFGE profiles of the Shigella sonnei biotype g isolates, 
1971–1980. Lanes: 1, Salmonella Braenderup H9812 (molec-
ular weight standard); 2–16, S. sonnei biotype g isolates: 2, 
Catanzaro, Calabria, 1979; 3, Palermo, Sicily, 1972; 4, Pal-
ermo 1975; 5, Palermo 1971; 6, Catanzaro 1979; 7, Palermo 
1972; 8, Palermo 1973; 9, Catanzaro 1979; 10, Palermo 1972; 
11, Cosenza, Calabria, 1979; 12, Palermo 1971; 13, Palermo 
1973; 14, Catanzaro 1979; 15, Palermo 1971; 16, Palermo 
1975.
1      2      3     4     5      6     7     8     9     10   11   12    13   14   15    16 Kbp
1135
668.9
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336.5     
310.1
244.4    
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104.5
78.2
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ologies and by more efficient international surveillance
networks.
Conclusion
Our findings prove that emergence of biotype g, class 2
integron carrying S. sonnei should be backdated to at least
the late 1980s, when a circulation of closely related strains
is confirmed also by the substantial homogeneity of PFGE
profiles in comparison with the striking heterogeneity of
the decade 1971–'80. The hypothesis is, of course, con-
servative because of the limits of our retrospective study
due to the inherent poor sensitivity of passive surveillance
systems and the restricted availability of viable strains for
analysis.
In our geographic area, like in many countries, shifting to
streptomycin or trimethoprim as the elective therapeutic
option was largely adopted after the emergence in the
1950s of sulfonamide resistant strains of Shigella  spp.
Hence, in the course of the three decades under study, the
presence of a class 2 integron might have positively driven
the successful epidemiological evolution and spread of a
streptomycin-trimethoprim resistant lineage.
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